| 2010 |
Crystal structures of two domains of human trifunctional GART were solved: the glycinamide ribonucleotide synthetase (GARS) domain and the aminoimidazole ribonucleotide synthetase (AIRS) domain. Small-angle X-ray scattering models of the full-length protein indicate it forms a dimer through the middle domain, with an approximate seesaw geometry where terminal enzyme units display high mobility owing to flexible linker segments, potentially facilitating internal substrate/product transfer. |
X-ray crystallography of individual domains; small-angle X-ray scattering (SAXS) of full-length protein |
Nucleic acids research |
High |
20631005
|
| 2001 |
Electrostatic calculations using the crystal structure of a GART ternary complex (with pseudosubstrate 5-deaza-5,6,7,8-THF and substrate GAR) showed strong electrostatic coupling among active-site residues His108, Asp144, and substrate GAR. His108 acts as an acid catalyst (forming a salt bridge with Asp144) and GAR acts as a nucleophile, with His137 also providing critical three-way electrostatic stabilization of the catalytic site. Proton exchange between GAR and His108 is geometry- and distance-dependent. |
Poisson-Boltzmann electrostatic calculations on crystallographic ternary complex; theoretical mutagenesis and deletion constructs |
Protein science |
Medium |
11604543
|
| 2003 |
Continuum electrostatic calculations on GART revealed that a network of five histidines (His108, His119, His121, His132, His137) and two aspartic acids (Asp141, Asp144) contributes ~12 kcal/mol of the ~16 kcal/mol total stability of the catalytic site, with the His121-His132 interaction contributing ~2.2 kcal/mol to ionization free energy, demonstrating the importance of this histidine network for catalytic-site stability. |
Continuum electrostatic calculations and structural modeling of activation helix stability |
Biophysical chemistry |
Low |
14499900
|
| 1997 |
The human GARS-AIRS-GART gene encodes not only the trifunctional 110 kDa protein but also a monofunctional 50 kDa GARS protein produced by alternative splicing that uses a polyadenylation site in the intron between the terminal GARS and first AIRS exons. Both proteins are developmentally regulated in human cerebellum. |
Western blot with domain-specific monoclonal and polyclonal antibodies on CHO cells transfected with human GARS-AIRS-GART gene; developmental expression analysis |
Human molecular genetics |
High |
9328467
|
| 2008 |
Loss-of-function mutations in zebrafish gart (encoding the trifunctional GARS/AIRS/GART enzyme) result in pigmentation defects (absent xanthophore and iridophore pigmentation, reduced melanin) and microphthalmia due to failure of cell cycle exit of proliferative retinoblasts. Pigmentation defects arise from GTP pathway deficiency while microphthalmia arises from ATP pathway deficiency, with S phase of retinoblasts prolonged in ATP-deficient conditions. |
Zebrafish recessive mutation analysis; genetic complementation; purine metabolite rescue experiments |
Development (Cambridge, England) |
High |
19570845
|
| 2008 |
Active site mutagenesis in CHO cells demonstrated that glutamate-75 is essential for GARS enzymatic activity and glycine-684 is essential for AIRS enzymatic activity of the trifunctional GART protein. |
Site-directed mutagenesis in CHO-K1 cells; purine auxotrophy selection; mRNA and protein analysis |
Gene |
Medium |
19007868
|
| 2023 |
GART was found to have a novel methyltransferase activity with enzymatic activity center at residue E948. GART methylates RuvB-like AAA ATPase 1 (RUVBL1) at its K7 site, enhancing RUVBL1 protein stability, which consequently aberrantly activates Wnt/β-catenin signaling to promote tumor stemness in colorectal cancer. |
In vitro methyltransferase assay; site-directed mutagenesis (E948); Co-IP; western blot; in vivo xenograft and PDX models |
Advanced science (Weinheim, Baden-Wurttemberg, Germany) |
Medium |
37439412
|
| 2025 |
Under glucose limitation, AMPK phosphorylates GART at Ser440, facilitating GART's interaction with UCK2. GART's catalytic activity generates tetrahydrofolate (THF), which inhibits ILKAP phosphatase activity, thereby preventing ILKAP from removing AKT1-mediated UCK2-Ser254 phosphorylation. Loss of UCK2-Ser254 phosphorylation causes Trim21-mediated UCK2 polyubiquitination and degradation. Thus GART (via both direct binding and THF production) maintains UCK2 stability and pyrimidine salvage synthesis for tumor growth under glucose limitation. |
Co-IP; western blot; phosphorylation assays; siRNA knockdown; biochemical reconstitution of AMPK phosphorylation; xenograft models |
Oncogene |
Medium |
39865175
|
| 2025 |
GART binds to and stabilizes HSP90α protein, thereby upregulating its client protein CDK6, and activates the Wnt/β-catenin pathway to promote cell proliferation and stemness gene expression in multiple myeloma cells. |
Co-IP; lentivirus-based overexpression; siRNA knockdown; in vivo plasmacytoma mouse model; CDX xenograft model |
European journal of pharmacology |
Medium |
40185325
|
| 2025 |
GART knockdown in lung cancer cells inhibits activation of the PAICS-Akt-β-catenin pathway, suppressing cell proliferation and migration both in vitro and in vivo, placing GART upstream of PAICS in this signaling axis. |
siRNA knockdown; qRT-PCR; western blot; CCK-8, colony formation, wound healing assays; xenograft tumor model |
Frontiers in oncology |
Low |
40201340
|
| 2016 |
GART inhibition in intestinal epithelial cells (IECs) induces apoptosis and suppresses IEC migration through activation of the MEKK3-MKK3-p38 MAPK pathway, followed by dysregulation of p53 and PUMA, establishing GART as a pro-survival regulator of intestinal epithelial barrier integrity. |
siRNA knockdown in cultured IECs; apoptosis assays; migration assays; western blot for pathway components |
Apoptosis |
Low |
27718035
|
| 2023 |
GART inhibition (via siRNA or lometrexol) induces ERα degradation and prevents breast cancer cell proliferation; VGLL3 transcription factor induces GART expression, and GART knockdown or lometrexol represses proliferation of VGLL3-high cancer cells in a manner rescuable by IMP supplementation. |
siRNA-based functional screen; metabolomic analysis; VGLL3 stable overexpression; lometrexol inhibitor; IMP rescue experiments |
Frontiers in endocrinology / Journal of cellular biochemistry |
Medium |
35434822 37143728
|
| 2023 |
Gart in Drosophila is expressed in glia, fat body, and gut, and is directly transcriptionally regulated by the CLOCK/CYCLE heterodimer via canonical E-box elements. CLK in glia, fat body, and gut positively regulates peripheral Gart, while brain-core CLK negatively controls peripheral Gart. Gut Gart maintains endogenous feeding rhythms and food intake, while glia/fat body Gart regulates energy homeostasis. |
Tissue-specific Gart knockdown; reporter assays for E-box-driven Gart transcription; behavioral feeding assays; genetic epistasis |
Cell reports |
Medium |
37531254
|
| 2026 |
In Drosophila, NPF signaling via its receptor NPFR positively regulates Gart expression specifically in the intestine, and Gart activity exerts negative feedback on NPF expression, forming a reciprocal regulatory loop. Genetic epistasis experiments demonstrate that gut Gart acts downstream of NPF. Peripheral (fat body/gut-derived) NPF, rather than brain-derived NPF, is the primary systemic signal driving this loop. |
Genetic epistasis; tissue-specific knockdown; feeding behavior assays; NPF receptor manipulation |
Insects |
Medium |
42188194
|
| 1991 |
The human GART gene (spanning ~40 kb on chromosome 21q22.1) encodes the trifunctional protein with GARS, GART, and AIRS activities and is functional when transferred into GARS- or GARS/AIRS-deficient CHO cells via YAC DNA, confirming that a single gene complements all three enzymatic deficiencies. |
YAC DNA transfer by lipofection and spheroplast fusion into mutant CHO cells; complementation of purine auxotrophy; restriction analysis of transferred DNA |
The EMBO journal |
High |
2050105
|